Clinical Trial Update: AMPLATZER™ LAA Occluder Post Approval Study (PAS)

View source ↗

Summary

This is a post-approval study update for the AMPLATZER LAA Occluder, reporting completed results and posted findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke
• Thromboembolism

Drugs mentioned

• AMPLATZER LAA Occluder (left atrial appendage occluder)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation, Thromboembolism | Status: COMPLETED | Results posted: 2024-03-29